 - The participant has symptomatic, active, or untreated central nervous system CNS metastases. Brain metastases that are asymptomatic, stable and not requiring steroid use, and previously treated by radiation are allowed. The participant may have no evidence of Grade 1 CNS hemorrhage based on pretreatment MRI or I.V. contrast CT scan performed within 21 days before first dose of study treatment. 